Embolotherapy in the Management of Gynecologic Neoplasms

  • Robert L. Worthington-Kirsch
Reference work entry


Endovascular embolization techniques have been used in the treatment of many disorders for over 30 years. In the management of gynecologic neoplasms, embolization is now a standard care option for treatment of symptomatic fibroids. Embolization allows for definitive treatment of fibroid disease in the majority of women, with a lower complication risk and faster recovery than more invasive surgical therapies. Historically embolotherapy has not had a great role to play in the treatment of gynecologic malignancies. New embolic technologies, especially drug-eluting embolics, may hold promise for the future.


Uterine Artery Embolization Embolic Agent Gelatin Sponge Uterine Fibroid Embolization Symptomatic Fibroid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Rosch J, Dotter CT, Brown MJ. Selective arterial embolization: a new method for control of acute gastrointestinal bleeding. Radiology. 1972;102:303–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Margolies MN, Ring EJ, Waltman AC, et al. Arteriography in the management of hemorrhage from pelvic fractures. N Engl J Med. 1972;287:318–21.CrossRefGoogle Scholar
  3. 3.
    Chuang VP, Soo CS, Wallace S, et al. Arterial occlusion: management of giant cell tumor and aneurysmal bone cyst. AJR Am J Roentgenol. 1981;136:1127–30.CrossRefPubMedGoogle Scholar
  4. 4.
    Wallace S, Chuang VP, Swanson D, et al. Embolization of renal cell carcinoma. Radiology. 1981;138:563–70.CrossRefPubMedGoogle Scholar
  5. 5.
    Lang EK, Deutsch JS, Goodman JR, et al. Transcatheter embolization of hypogastric artery branches in the management of intractable bladder hemorrhage. J Urol. 1979;121:30–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Soulen MC, Faykus MH, Shlansky-Goldberg RD, et al. Elective embolization for prevention of hemorrhage from renal angiomyolipomas. J Vasc Interv Radiol. 1994;5:587–91.CrossRefPubMedGoogle Scholar
  7. 7.
    Giavroglou C, Economou H, Ioannidis I. Arterial embolization of giant hepatic hemangiomas. Cardiovasc Intervent Radiol. 2003;26:92–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Kalman D, Varenhorst E. The role of arterial embolization in renal cell carcinoma. Scand J Urol Nephrol. 1999;33:162–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Sun S. Bone metastases from renal cell carcinoma: preoperative embolization. In: Golzarian J, Sun S, Sharafuddin MJ, editors. Vascular embolotherapy: a comprehensive approach, vol. 2. Berlin: Springer; 2006. p. 189–99.CrossRefGoogle Scholar
  10. 10.
    Yalvac S, Kayikcioglu F, Borna N, et al. Embolization of uterine artery in terminal stage cervical cancers. Cancer Invest. 2002;20:754–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Morrissey DD, Andersen PE, Nesbit GM, et al. Endovascular management of hemorrhage in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1997;123:15–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Konno T, Maeda H, Iwai K, et al. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphangiographic agent on hepatoma. Eur J Cancer Clin Oncol. 1983;19:1053–65.CrossRefPubMedGoogle Scholar
  13. 13.
    Heaston DK, Mineau DE, Brown BJ, Miller FJ. Transcatheter arterial embolization for the control of persistent massive puerperal hemorrhage after bilateral surgical hypogastric artery ligation. AJR Am J Roentgenol. 1979;133:152–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Oliver JA, Lance JS. Selective embolization to control massive hemorrhage following pelvic surgery. Am J Obstet Gynecol. 1979;135:431–2.CrossRefPubMedGoogle Scholar
  15. 15.
    Stancato-Pasik A, Mitty HA, Richard III HM, Eshkkar NS. Obstetric embolotherapy: effect on menses and pregnancy. Radiology. 1996;201:179.CrossRefGoogle Scholar
  16. 16.
    Shinagawa S, Nomura Y, Kudoh S. Full-term deliveries after ligation ofbilateral internal iliac arteries and infundibulopelvic ligaments. Acta Gynecol Obstet Scand. 1981;60:439–40.CrossRefGoogle Scholar
  17. 17.
    Cramer SF, Patel D. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94:435–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Schwartz SM. Epidemiology of uterine leiomyomata. Clin Obstet Gynecol. 2001;44:316–26.CrossRefPubMedGoogle Scholar
  19. 19.
    Greenberg MD, Kazamel TIG. Medical and socioeconomic impact of uterine fibroids. Obstet Gynecol Clin North Am. 1995;22:625–36.PubMedGoogle Scholar
  20. 20.
    Stovall DE. Clinical symptomatology of uterine leiomyomas. Clin Obstet Gynecol. 2001;44:364–71.CrossRefPubMedGoogle Scholar
  21. 21.
    Forman RG, Reidy J, Nott V, Braude P. Fibroids and fertility. Min Invas Ther Allied Technol. 1999;8:415–9.CrossRefGoogle Scholar
  22. 22.
    Rice JP, Kay HH, Mahony BS. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol. 1989;8:517–26.Google Scholar
  23. 23.
    Ravina JH, Bouret JM, Fried D, et al. Value of preoperative embolization of uterine fibroma: report of a multicenter series of 31 cases. Contracept Fertil Sex. 1995;23:45–9.PubMedGoogle Scholar
  24. 24.
    Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346:671–2.CrossRefPubMedGoogle Scholar
  25. 25.
    McLucas B, Goodwin SC. A fibroid treatment with promise – and a catch. OBG Manage. 1996;8:53–7.Google Scholar
  26. 26.
    Worthington-Kirsch RL, Hutchins FL, Popky GL. Uterine artery embolization for the management of leiomyomas: quality of life assessment and clinical response. Radiology. 1998;208:625–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Zurawin RK, Fischer JH, Amir L. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma. J Min Invas Gynecol. 2010;17:214–21.CrossRefGoogle Scholar
  28. 28.
    Vedantham S, Sterling KM, Goodwin SC, et al. Uterine fibroid embolization: preprocedure assessment. Tech Vasc Interv Radiol. 2002;5:2–16.CrossRefPubMedGoogle Scholar
  29. 29.
    Andrews RT, Spies JB, Sacks D, et al. Patient care and uterine artery embolization for leiomyomata. J Vasc Interv Radiol. 2004;15:115–20.CrossRefPubMedGoogle Scholar
  30. 30.
    Firouznia K, Ghanaati H, Sanaati M, Jalali AH, Shakiba M. Uterine artery embolization in 101 cases of uterine fibroids: do size, location, and number of fibroids affect therapeutic success and complications? Cardiovasc Intervent Radiol. 2008;31:521–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Chrisman HB, Minocha J, Ryu RK, Vogelzang RL, Nikolaidis P, Omary RA. Uterine artery embolization: a treatment option for symptomatic fibroids in postmenopausal women. J Vasc Interv Radiol. 2007;18:451–4.CrossRefPubMedGoogle Scholar
  32. 32.
    Usadi R, Marshburn PB. The impact of uterine artery embolization on fertility and pregnancy outcome. Curr Opin Obstet Gynecol. 2007;19:279–83.CrossRefPubMedGoogle Scholar
  33. 33.
    Azziz R. Adenomyosis: current persectives. Obstet Gynecol Clin North Am. 1989;16:221–35.PubMedGoogle Scholar
  34. 34.
    Dueholm M, Lundorf E, Sorensen JS, Ledertoug S, Olesen F. Reproducibility of evaluation of the uterus by transvaginal sonography, hysterosongraphic examination, hysteroscopy and magnetic resonance imaging. Hum Reprod. 2002;17:195–200.CrossRefPubMedGoogle Scholar
  35. 35.
    Pelage JP, Jacob D, Fazel A, et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology. 2005;234:948–53.CrossRefPubMedGoogle Scholar
  36. 36.
    Kim MD, Kim S, Kim NK, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol. 2007;188:176–81.CrossRefPubMedGoogle Scholar
  37. 37.
    Goldberg J. Uterine artery embolization for adenomyosis: looking at the glass half full. Radiology. 2005;236:1111–2.CrossRefPubMedGoogle Scholar
  38. 38.
    Pelage JP, Jacob D, leDref O. Dr Pelage and colleagues respond. Radiology. 2005;236:1111–2.Google Scholar
  39. 39.
    Worthington-Kirsch RL, Andrews RT, Siskin GP, et al. Uterine fibroid embolization: technical aspects. Tech Vasc Interv Radiol. 2002;5:17–34.CrossRefPubMedGoogle Scholar
  40. 40.
    Worthington-Kirsch RL, Spies JB, Myers ER, et al. The fibroid registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol. 2005;106:52–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M. The FIBROID registry: symptoms and quality-of-Life status 1 year after therapy. Obstet Gynecol. 2005;106:1309–18.CrossRefPubMedGoogle Scholar
  42. 42.
    Goodwin SC, Spies JB, Worthington-Kirsch R, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID registry. Obstet Gynecol. 2008;111:22–33.CrossRefPubMedGoogle Scholar
  43. 43.
    Spies JB, Bruno J, Czeyda-Pommersheim F, Magee S, Ascher SA, Jha RC. Long-term outcomes of uterine artery embolization of leiomyomata. Obstet Gynecol. 2005;106:933–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Kempson RL, Bari W. Uterine sarcomas: classification, diagnosis, and prognosis. Hum Pathol. 1970;1:331–49.CrossRefPubMedGoogle Scholar
  45. 45.
    Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol. 2004;93:204–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Leibsohn S, d’Aiblang G, Mishell DR, Schlaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol. 1990;162:968–76.CrossRefPubMedGoogle Scholar
  47. 47.
    Common AA, Mocarski EJ, Kolin A, Pron G, Soucie J. Therapeutic failure of uterine fibroid embolization caused by underlying leiomyosarcoma. J Vasc Interv Radiol. 2001;12:1449–52.CrossRefPubMedGoogle Scholar
  48. 48.
    Goldberg J, Burd I, Price FV, Worthington-Kirsch R. Leiomyosarcoma in a premenopausal patient after uterine artery embolization. Am J Obstet Gynecol. 2004;191:1733–5.CrossRefPubMedGoogle Scholar
  49. 49.
    Cromer JK, Bateman JC, Berry GN, Kennelly JM, Klopp CT, Platt LI. Use of intra-arterial nitrogen mustard therapy in the treatment of cervical and vaginal cancer. Am J Obstet Gynecol. 1952;63:538–48.CrossRefPubMedGoogle Scholar
  50. 50.
    Carlson JA, Freedman RS, Wallace S, Chuang VP, Wharton JP, Rutledge FN. Intra-arterial cis-platinum in the management of squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1981;12:92–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Pisco JM, Martins JM, Correia MG. Internal iliac artery: embolization to control hemorrhage from pelvic neoplasms. Radiology. 1989;172:337–9.CrossRefPubMedGoogle Scholar
  52. 52.
    Yamashita Y, Harada M, Yamamoto H, et al. Transcatheter arterial embolization of obstetric and gynaecologic bleeding: efficacy and clinical outcome. Br J Radiol. 1994;67:530–4.CrossRefPubMedGoogle Scholar
  53. 53.
    Vedantham S, Godowin SC, McLucas B, Mohr G. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol. 1997;176:938–48.CrossRefPubMedGoogle Scholar
  54. 54.
    Hayashi M, Murakami A, Iwasaki N, Yaoi Y. Effectiveness of arterial embolization procedure in uterine cancer patients. J Med. 1999;30:225–34.PubMedGoogle Scholar
  55. 55.
    Adachi S, Yamasaki N, Ogasawara T, Takayasu Y, Takemura T, Koyama K. Combination chemotherapy using intravenous nedaplatin (254-S) and intraarterial cisplatin (CDDP) with transcatheter arterial embolization (TAE) for a patient with uterine cervical cancer: a case report. Jpn J Clin Oncol. 1997;27:442–4.CrossRefPubMedGoogle Scholar
  56. 56.
    Adachi S, Ogasawara T, Tsubamoto H, et al. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer. Int J Pharmacol Res. 2001;21:105–10.Google Scholar
  57. 57.
    Shimizu Y. Recent advances in intraarterial chemotherapy in gynecologic malignancy. Gan To Kagaku Ryoho. 2002;29:189–96.PubMedGoogle Scholar
  58. 58.
    Morrison J, Swanton A, Collins S, Kehoe S. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst Rev. 2007;4:Art No. CD005343.Google Scholar
  59. 59.
    Taylor RR, Tang Y, Gonzalez MV, Straftord PW, Lewis AL. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharmacol Sci. 2007;30:7–14.CrossRefGoogle Scholar
  60. 60.
    Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol. 2006;17:1335–43.CrossRefPubMedGoogle Scholar
  61. 61.
    Cheng BQ, Jia CQ, Liu CT, et al. Chemoembolization combined with radiofrequency ablation for patient with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299:1669–77.CrossRefPubMedGoogle Scholar
  62. 62.
    Yamakado K, Nakatsuka A, Takaki H, et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology. 2008;247:260–6.CrossRefPubMedGoogle Scholar
  63. 63.
    Xu KC, Niu LZ, Zhou Q, et al. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol. 2009;15:3664–9.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Vein Clinics of AmericaWayneUSA

Personalised recommendations